ArticlePloS one2024
Effects of prebiotic and multispecies probiotic supplementation on the gut microbiota, immune function, and growth performance of weaned piglets.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Insights into pig resilience: the Microbiome-genetic connection.Porcine health management · 2026Review
- A ProbioticMicroorganisms · 2026Article
- Efficacy of Three Doses of Halquinol on Growth Performance, Diarrhea Incidence, Nutrient Digestibility, and Fecal Microbiome of Weaned Pigs.Animals : an open access journal from MDPI · 2025Article
- Immunomodulatory effects ofFrontiers in immunology · 2025Article
- Complex probiotics can reduce diarrhea by boosting immunity and balancing gut microbiota in weaned piglets.Frontiers in immunology · 2025Article
- The Weaning of Pigs: Mechanistic Outcomes to Intestinal Immunity and Integrity.Animal science journal = Nihon chikusan GakkaihoReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we evaluated the impact of yeast cell wall prebiotics and multispecies probiotics on the gut microbiota, immune response, and growth performance of weaned piglets, as alternatives to antibiotics as growth promoters (AGPs). A randomized complete block design was employed, involving 160 piglets divided into four treatment groups during the nursery phase. The treatments applied throughout the experimental period were as follows: CONT+ = basal diet with halquinol (AGP); YCW = basal diet with yeast cell wall (cell wall of Saccharomyces cerevisiae yeast); SIM+ = basal diet with yeast cell wall + multispecies probiotic (Bacillus subtilis (2.0 x 109 CFU/g), Bacillus coagulans (5.0 x 108 CFU/g), Clostridium butyricum (5.0 x 107 CFU/g), and Bacillus licheniformis (2.0 x 109 CFU/g)); SIM- = basal diet with yeast cell wall + multispecies probiotic (half dose). The parameters assessed included daily feed intake, weight gain, feed conversion ratio (FCR), diarrhea score, serum cytokine levels, and chemokine concentrations, as well as microbiota analysis. During the 21 to 63-day study period, only FCR differed significantly (p = 0.0076). CONT+ and PREB had superior FCRs of 1.543 and 1.585, while SIM- had the least favorable FCR at 1.654. At 35 days, IL-10 levels were greater in the SIM- group, showing a 271.25% increase over those in the other groups. By 49 days, the IL-8 concentration was lower in the PREB group than in the CONT+ group, with a reduction of 247%, while the IL-8 concentrations in the SIM+ and SIM- groups were not significantly different from those in the other groups. The Firmicutes/Bacteroidetes (F/B) ratio in the CONT+ group was lower than that in the PREB, SIM+, and SIM- treatment groups. The Lactobacillaceae family was more abundant in the SIM+ treatment, followed by the SIM- and PREB treatments. The CONT+ treatment had the lowest abundance. The abundance of the genus Lactobacillus differed between the CONT+ group and the PREB, SIM+, and SIM- treatment groups. Prebiotics, used either alone or combined with probiotics, serve as effective substitutes for AGPs, boosting piglets' health and performance throughout the nursery phase.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.